Australian Technical Advisory Group on Immunisation (ATAGI)

Updated advice on the use of pandemic and seasonal influenza vaccines in children <10 years of age
Updated: 26 August 2010

The entire ATAGI Updated advice on the use of pandemic and seasonal influenza vaccines in children <10 years of age can be viewed on the PDF file below:

ATAGI Updated advice on the use of pandemic and seasonal influenza vaccines in children <10 years of age. (26 August 2010)

• Strongest demand for phone-based chronic disease support coming from the over 55’s,
  reducing pressure on hospital services
• Cardiac and musculoskeletal problems overtake diabetes as the most common chronic
  conditions reported by My Health Guardian users

HCF Media Release - My Health Guardian

Please distribute this information to all practice staff
Recommendation

Currently there is a suspension of the use of trivalent influenza vaccine for health children under 5. This restriction can now be lifted provided the trivalent influenza vaccines Vaxigrip or Influvac are used. This is based on additional data confirming low rates of fever with convulsions similar to that documented for trivalent influenza vaccine in previous years.

Although Fluvax remains a registered trivalent influenza vaccine for use in children aged less than 5 years, the accumulated data on increased rates of fever and febrile convulsions within 24 hours of immunisation with the 2010 Fluvax in children less than 5 years of age has led to a recommendation for the use of alternative available influenza vaccines in this age group.

	Media Statement as at 30 July 2010 - 10:20am FINAL
	Fact Sheet - Use of Seasonal Influenza in Young Children 30 July 2010 - 10:20am FINAL
	ATAGI Summary table TIV FINAL as at 30 July 2010 - 10:20am
	ATAGI Use of TIV all children FINAL as at 30 July 2010 - 10:20am
	CMO Letter 30 July 2010 - 10:30am FINAL

MEDIA STATEMENT

"After consideration of the results to date of a comprehensive investigation into the safety of the seasonal flu vaccine for young children, I have advised, that as a precaution, the suspension of seasonal flu vaccination should continue for healthy children under five years of age."

Professor Jim Bishop AO
MD MMed MBBS FRACP FRCPA
Commonwealth Chief Medical Officer

The entire Media Statement by the Chief Medical Officer can be viewed on the PDF file below:

NSW Health Seasonal Influenza Vaccination Update 01 06 2010 Media Statement.

NOW TAKING REFERRALS – ITEM 713

WHAT is the Lifestyle Modification Program?

• Provided by accredited health professionals (diabetes educators, exercise physiologists and dieticians) it involves 10 hours of small group education over six months.
• Patients learn about healthy eating, exercising and staying motivated.
• It involves moderate physical exercise and supports participants in making lasting changes.

WHO is eligible for the subsidy?

• If you have billed a 710, 713 or 717 and the patient has scored ≥15 on AUSDRISK (but DOES NOT have diabetes) they can attend the program for only $50.00 with UNSW Lifestyle Clinic and $10 with Diabetes Australia – NSW (full cost is $264.00).
• Health care and concession card holders receive the course for free.

HOW To Refer?

• Fill in the AUSDRISK and General Practitioner Referral Form (PDF on website)

• Call the Division on 9389 0874 for a Diabetes Unique Identifier (DUI) and fax the referral to the Division on 9387 4175 for processing

For more information please contact Candi on 9389 0874 ext 203.
This information can be found on the LMP section of the website. Please follow the link below

 Lifestyle Modification Program - LMP